Gerhard Hindricks to United States
This is a "connection" page, showing publications Gerhard Hindricks has written about United States.
Connection Strength
0.006
-
Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation. Europace. 2017 01; 19(1):132-138.
Score: 0.006